Human equilibrative nucleoside transporter-1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression; do they have survival impact to pancreatic cancer?

BACKGROUNDS/AIMS: Gemcitabine is still one of adjuvant options in chemotherapeutic agent for pancreatic ductal adenocarcinoma (PDAC). Integral membrane transporter protein and intracellular enzymes including human equilibrative nucleoside transporter 1 (hENT1), deoxycytidine kinase (dCK), ribonucleo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Hepatobiliary Pancreat Surg
Hlavní autoři: Hwang, Dae Wook, Shin, Eun, Cho, Jai Young, Han, Ho-Seong, Yoon, Yoo-Seok
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Association of Hepato-Biliary-Pancreatic Surgery 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7271117/
https://ncbi.nlm.nih.gov/pubmed/32457256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14701/ahbps.2020.24.2.127
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky